Cargando…
P634: EARLY-STAGE MEASURABLE RESIDUAL DISEASE DYNAMICS AND IGHV REPERTOIRE RECONSTITUTION DURING VENETOCLAX AND OBINUTUZUMAB TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429050/ http://dx.doi.org/10.1097/01.HS9.0000969440.63949.3f |
| _version_ | 1785090618310000640 |
|---|---|
| author | Hengeveld, Paul Schilperoord-Vermeulen, Joyce van der Klift, Michèle Dubois, Julie Martijn Kolijn, Pieter Kavelaars, François Rijken, Melissa Dobber, Johan Nasserinejad, Kazem Kersting, Sabina Westerweel, Peter Kater, Arnon Langerak, Anton Levin, Mark-David |
| author_facet | Hengeveld, Paul Schilperoord-Vermeulen, Joyce van der Klift, Michèle Dubois, Julie Martijn Kolijn, Pieter Kavelaars, François Rijken, Melissa Dobber, Johan Nasserinejad, Kazem Kersting, Sabina Westerweel, Peter Kater, Arnon Langerak, Anton Levin, Mark-David |
| author_sort | Hengeveld, Paul |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429050 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104290502023-08-17 P634: EARLY-STAGE MEASURABLE RESIDUAL DISEASE DYNAMICS AND IGHV REPERTOIRE RECONSTITUTION DURING VENETOCLAX AND OBINUTUZUMAB TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA Hengeveld, Paul Schilperoord-Vermeulen, Joyce van der Klift, Michèle Dubois, Julie Martijn Kolijn, Pieter Kavelaars, François Rijken, Melissa Dobber, Johan Nasserinejad, Kazem Kersting, Sabina Westerweel, Peter Kater, Arnon Langerak, Anton Levin, Mark-David Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429050/ http://dx.doi.org/10.1097/01.HS9.0000969440.63949.3f Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Hengeveld, Paul Schilperoord-Vermeulen, Joyce van der Klift, Michèle Dubois, Julie Martijn Kolijn, Pieter Kavelaars, François Rijken, Melissa Dobber, Johan Nasserinejad, Kazem Kersting, Sabina Westerweel, Peter Kater, Arnon Langerak, Anton Levin, Mark-David P634: EARLY-STAGE MEASURABLE RESIDUAL DISEASE DYNAMICS AND IGHV REPERTOIRE RECONSTITUTION DURING VENETOCLAX AND OBINUTUZUMAB TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| title | P634: EARLY-STAGE MEASURABLE RESIDUAL DISEASE DYNAMICS AND IGHV REPERTOIRE RECONSTITUTION DURING VENETOCLAX AND OBINUTUZUMAB TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_full | P634: EARLY-STAGE MEASURABLE RESIDUAL DISEASE DYNAMICS AND IGHV REPERTOIRE RECONSTITUTION DURING VENETOCLAX AND OBINUTUZUMAB TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_fullStr | P634: EARLY-STAGE MEASURABLE RESIDUAL DISEASE DYNAMICS AND IGHV REPERTOIRE RECONSTITUTION DURING VENETOCLAX AND OBINUTUZUMAB TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_full_unstemmed | P634: EARLY-STAGE MEASURABLE RESIDUAL DISEASE DYNAMICS AND IGHV REPERTOIRE RECONSTITUTION DURING VENETOCLAX AND OBINUTUZUMAB TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_short | P634: EARLY-STAGE MEASURABLE RESIDUAL DISEASE DYNAMICS AND IGHV REPERTOIRE RECONSTITUTION DURING VENETOCLAX AND OBINUTUZUMAB TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_sort | p634: early-stage measurable residual disease dynamics and ighv repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429050/ http://dx.doi.org/10.1097/01.HS9.0000969440.63949.3f |
| work_keys_str_mv | AT hengeveldpaul p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT schilperoordvermeulenjoyce p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT vanderkliftmichele p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT duboisjulie p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT martijnkolijnpieter p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT kavelaarsfrancois p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT rijkenmelissa p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT dobberjohan p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT nasserinejadkazem p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT kerstingsabina p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT westerweelpeter p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT katerarnon p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT langerakanton p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia AT levinmarkdavid p634earlystagemeasurableresidualdiseasedynamicsandighvrepertoirereconstitutionduringvenetoclaxandobinutuzumabtreatmentinchroniclymphocyticleukemia |